About Us

Our News

First neuroblastoma patient successfully dosed with innovative CAR therapy utilizing natural killer T cells (CAR-NKT)

Transforming the lives of patients with cancer by developing off-the-shelf CAR-NKT cell therapy

Read More...

Cell Medica Appoints New CEO to Drive CAR and TCR Clinical Development and Commercialisation

Transforming the lives of patients with cancer by developing off-the-shelf CAR-NKT cell therapy

Read More...

Publication of ASPIRE Clinical Trial Results

Transforming the lives of patients with cancer by developing off-the-shelf CAR-NKT cell therapy

Read More...

Cell and Gene Therapy Catapult manufacturing centre officially opens

Transforming the lives of patients with cancer by developing off-the-shelf CAR-NKT cell therapy

Read More...
More News Posts